Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacogenetic analysis of canonical versus noncanonical pathway of NF-kB in Crohn's disease patients under anti-tumor necrosis factor-α treatment.
Stavrou EF, Chatzopoulou F, Antonatos C, Pappa P, Makridou E, Oikonomou K, Kapsoritakis A, Potamianos PS, Karmiris K, Tzathas C, Chatzidimitriou D, Vizirianakis IS, Vasilopoulos Y. Stavrou EF, et al. Among authors: vasilopoulos y. Pharmacogenet Genomics. 2022 Aug 1;32(6):235-241. doi: 10.1097/FPC.0000000000000471. Epub 2022 Jun 22. Pharmacogenet Genomics. 2022. PMID: 35852914
Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis.
Montes A, Perez-Pampin E, Narváez J, Cañete JD, Navarro-Sarabia F, Moreira V, Fernández-Nebro A, Del Carmen Ordóñez M, de la Serna AR, Magallares B, Vasilopoulos Y, Sarafidou T, Caliz R, Ferrer MA, Joven B, Carreira P, Gómez-Reino JJ, Gonzalez A. Montes A, et al. Among authors: vasilopoulos y. Pharmacogenet Genomics. 2014 May;24(5):238-45. doi: 10.1097/FPC.0000000000000042. Pharmacogenet Genomics. 2014. PMID: 24667440
FCGR3A-V158F polymorphism is a disease-specific pharmacogenetic marker for the treatment of psoriasis with Fc-containing TNFα inhibitors.
Mendrinou E, Patsatsi A, Zafiriou E, Papadopoulou D, Aggelou L, Sarri C, Mamuris Z, Kyriakou A, Sotiriadis D, Roussaki-Schulze A, Sarafidou T, Vasilopoulos Y. Mendrinou E, et al. Among authors: vasilopoulos y. Pharmacogenomics J. 2017 Jun;17(3):237-241. doi: 10.1038/tpj.2016.16. Epub 2016 Apr 5. Pharmacogenomics J. 2017. PMID: 27044681
Protein network and pathway analysis in a pharmacogenetic study of cyclosporine treatment response in Greek patients with psoriasis.
Antonatos C, Patsatsi A, Zafiriou E, Stavrou EF, Liaropoulos A, Kyriakoy A, Evangelou E, Digka D, Roussaki-Schulze A, Sotiriadis D, Georgiou S, Grafanaki K, Moschonas NΚ, Vasilopoulos Y. Antonatos C, et al. Among authors: vasilopoulos y. Pharmacogenomics J. 2023 Jan;23(1):8-13. doi: 10.1038/s41397-022-00291-7. Epub 2022 Oct 13. Pharmacogenomics J. 2023. PMID: 36229649
50 results